Selected article for: "age gender and symptom onset"

Author: Su, Wei-Ju; Chan, Ta-Chien; Chuang, Pei-Hung; Liu, Yu-Lun; Lee, Ping-Ing; Liu, Ming-Tsan; Chuang, Jen-Hsiang
Title: Estimating influenza vaccine effectiveness using routine surveillance data among children aged 6–59 months for five consecutive influenza seasons
  • Cord-id: vrcoo0zt
  • Document date: 2014_11_18
  • ID: vrcoo0zt
    Snippet: OBJECTIVES: We aimed to estimate the pooled vaccine effectiveness (VE) in children over five winters through data linkage of two existing surveillance systems. METHODS: Five test-negative case–control studies were conducted from November to February during the 2004/2005 to 2008/2009 seasons. Sentinel physicians from the Viral Surveillance Network enrolled children aged 6–59 months with influenza-like illness to collect throat swabs. Through linking with a nationwide vaccination registry, we
    Document: OBJECTIVES: We aimed to estimate the pooled vaccine effectiveness (VE) in children over five winters through data linkage of two existing surveillance systems. METHODS: Five test-negative case–control studies were conducted from November to February during the 2004/2005 to 2008/2009 seasons. Sentinel physicians from the Viral Surveillance Network enrolled children aged 6–59 months with influenza-like illness to collect throat swabs. Through linking with a nationwide vaccination registry, we measured the VE with a logistic regression model adjusting for age, gender, and week of symptom onset. Both fixed-effects and random-effects models were used in the meta-analysis. RESULTS: Four thousand four hundred and ninety-four subjects were included. The proportion of influenza test-positive subjects across the five seasons was 11.5% (132/1151), 7.2% (41/572), 23.9% (189/791), 6.6% (75/1135), and 11.2% (95/845), respectively. The pooled VE was 62% (95% confidence interval (CI) 48–83%) in both meta-analysis models. By age category, VE was 51% (95% CI 23–68%) for those aged 6–23 months and 75% (95% CI 60–84%) for those aged 24–59 months. CONCLUSIONS: Influenza vaccination provided measurable protection against laboratory-confirmed influenza among children aged 6–59 months despite variations in the vaccine match during the 2004/2005 to 2008/2009 influenza seasons in Taiwan.

    Search related documents:
    Co phrase search for related documents
    • activity determine and acute respiratory infection: 1, 2, 3
    • activity determine and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • activity determine and logistic regression model: 1
    • acute respiratory disease and adjusted odd: 1
    • acute respiratory disease and adjusted odd ratio: 1
    • acute respiratory disease and logistic regression model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory infection and adjusted odd: 1
    • acute respiratory infection and adjusted odd ratio: 1
    • acute respiratory infection and logistic regression model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and adequate evidence: 1, 2, 3, 4, 5, 6
    • acute respiratory syndrome and adjusted odd: 1, 2, 3, 4, 5
    • acute respiratory syndrome and adjusted odd ratio: 1, 2, 3, 4, 5
    • acute respiratory syndrome and local strain: 1, 2, 3, 4, 5
    • acute respiratory syndrome and logistic regression model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • adjusted odd and logistic regression model: 1, 2
    • adjusted odd ratio and logistic regression model: 1, 2